Leandro Neves, Senior Global Director of R&D Genomics at LGC, discusses the technologies, challenges, and opportunities shaping the future of genomic analysis
Optimized mRNA constructs are designed for high on-target editing, reduced off-target activity with SpyFi, low toxicity, and delivery method flexibility
Study reveals previously unknown enzyme may influence susceptibility to lung fibrosis
Inocras CEO Jehee Suh and co-founder Young Seok Ju discuss how a collaboration with the Broad Institute is unlocking thousands of cancer whole genomes to advance precision oncology
Miniaturization and automated liquid handling transform NGS workflows for precious sample processing
Collaboration will bring next generation orchestration and modular automation to scientists worldwide
One test to diagnose all: In this guest editorial, Neil Ward, VP of PacBio EMEA, explores why current diagnostic pathways for rare diseases are falling short
Dr. Chia-Lin Wei, Professor of Genome Sciences at University of Washington, shares how to unlock DNA methylation insights for neuroscience and cancer research
Activace platform enables targeted, genome-wide profiling of unmethylated DNA regions, providing a comprehensive view of the epigenome that can be scaled to the study of large patient cohorts
Discover how experts at the London Natural History Museum are advancing molecular biology through cutting-edge automation and robotics
Enhanced’s 3D multi-omics platform delivers genetically validated targets for common diseases
Rob Walton, CEO of SPT Labtech, shares how a customer-centric approach is shaping the next generation of life science research and inspiring ingenuity
Breakthrough demonstrates the potential of 3D multi-omics to revolutionize drug discovery timelines and success rates across various disease area
Third Cytiva FlexFactory manufacturing platform will help the CDMO meet the rising demand for genomic medicines
As scientists uncover more links between gut bacteria and cancer, microbiome testing offers a promising approach to detect, treat, and even prevent the disease
Guest editorial features key takeaways from Balancing the Future Podcast, episode 8, by METTLER TOLEDO
See how the secrets of the genome and emerging gene editing technologies are revolutionizing life sciences research
Find out how to unlock cellular mysteries with Yokogawa’s Single Cellome™ System SS2000
Amp-Seq One offers reduced hands-on time and doubled throughput
Successes across the de-extinction pipeline signal that the thylacine project is on track as Colossal continues its global effort to fight the extinction crisis
Strategic agreement unites best-in-class technology with end-to-end development solutions to optimize therapeutic development process
Partnership to expand applications of DNA break-mapping technology and advance understanding of genomic instability in development of the neurodegenerative disease amyotrophic lateral sclerosis
Dr. Priya Chockalingam discusses the complexities of cell and gene therapies and how single-cell multimodal analysis can efficiently characterize gene-edited products
